Events

June 05, 2026 (12:00)

"Hacking Cell Death: Modulating MCL1 and BOK for Cancer Therapy"

Dr Mar Orzáez

IJC Auditorium + Online
Registration here

Invited Lectures

June 10, 2026 - June 12, 2026

5th International Clinical Epigenetics Conference (CLEPIC 2026)

CLEPIC 2026

IJC Auditorium
Registration here

Symposium

July 03, 2026 (12:00)

"50 years of measurable residual disease in malignant hemopathies: from submicroscopic detection of resistance to integral monitoring of therapy"

Dr Alberto Orfao

IJC Auditorium + Online
Registration here

Invited Lectures

July 08, 2026 (12:00)

"Networks of alternative splicing regulation in cancer"

Dr Juan Valcárcel Juárez

IJC Auditorium + Online
Registration here

Invited Lectures

Latest Publications

How should myelodysplastic neoplasms with isolated deletion 5q and TP53 multihit alterations be classified?

Incidence and survival of epithelial salivary glands cancer by tumor site and histology in Tarragona and Girona, Catalonia, Spain

DNA methylation and expression of MAPRE3 affect overall survival of early-stage non-small cell lung cancer patients

Endothelial Activation and Damage associated with Steroid-Refractory aGVHD is counteracted by Ruxolitinib

Latest news

For the first time, scientists discover that a subset of a common blood cancer is more deadly in women than in men — and find a new targeted treatment approach

May 06, 2026

For the first time, scientists discover that a subset of a common blood cancer is more deadly in women than in men — and find a new targeted treatment approach

New Molecular Tool Transforms How Clinicians Classify and Treat a Rare Blood Cancer

April 29, 2026

New Molecular Tool Transforms How Clinicians Classify and Treat a Rare Blood Cancer

Scientists Identify a “Protective Switch” in the Most Common Blood Cancer, Opening New Doors for Diagnosis and Treatment

April 20, 2026

Scientists Identify a “Protective Switch” in the Most Common Blood Cancer, Opening New Doors for Diagnosis and Treatment

New advances in understanding how the most common form of childhood cancer originates

April 08, 2026

New advances in understanding how the most common form of childhood cancer originates

Alessandro Ianni, from the Josep Carreras Institute, receives the Postdoctoral Junior Leader fellowship from la Caixa Foundation

April 01, 2026

Alessandro Ianni, from the Josep Carreras Institute, receives the Postdoctoral Junior Leader fellowship from la Caixa Foundation

Integration of single-cell multiomics data allows a more precise identification of rare cell types and states

March 27, 2026

Integration of single-cell multiomics data allows a more precise identification of rare cell types and states

The Josep Carreras Institute and the Chinese Institute of Hematology and Blood Diseases Hospital join forces to advance research in blood cancers

March 26, 2026

The Josep Carreras Institute and the Chinese Institute of Hematology and Blood Diseases Hospital join forces to advance research in blood cancers

Locations

IJC Josep Trueta

IJC Sant Joan de Déu

Who we are, in data

401

4 programs

39 Research Groups

340 Researchers and technicians

61 Management staff

244 Women

156 Men

1 Others